| Visualitzacions | |
|---|---|
| Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain) | 798 |
| octubre 2023 | novembre 2023 | desembre 2023 | gener 2024 | febrer 2024 | març 2024 | abril 2024 | |
|---|---|---|---|---|---|---|---|
| Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain) | 3 | 5 | 6 | 3 | 2 | 0 | 5 |
| Visualitzacions | |
|---|---|
| artconlli_a2005_gisbert_ramon_cost_benefit_cost_effectiveness.pdf | 1 |
| Visualitzacions | |
|---|---|
| Estats Units | 468 |
| França | 59 |
| Xina | 57 |
| Alemanya | 35 |
| Països Baixos | 34 |
| Suècia | 34 |
| Ucraïna | 30 |
| Rússia | 21 |
| Regne Unit | 19 |
| República Txeca | 7 |
| Visualitzacions | |
|---|---|
| Ashburn | 87 |
| Fairfield | 55 |
| Sunnyvale | 39 |
| Oakland | 32 |
| Mountain View | 30 |
| Cambridge | 24 |
| Beijing | 22 |
| Ann Arbor | 21 |
| Zhengzhou | 21 |
| Houston | 17 |